Solitomab

DB33767InvestigationalProtein Based Therapies

Solitomab: Overview.

Mechanism: Pharmacologically active on Epithelial cell adhesion molecule and T-cell surface glycoprotein CD3
Curator reviewed
Code names: MT110

Resolves to

Compound

Targets

What you can answer from here — as of August 28, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Solitomab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.